Research

• Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS

  Tim Spelman, Tomas Kalincik, Vilija Jokubaitis, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Shibeshih Belachew, Robert Hyde, Freek Verheul, Alessandra Lugaresi, Eva Havrdová, Dana Horáková, Pierre Grammond, Pierre Duquette, Alexandre Prat, Gerardo Iuliano, Murat Terzi, Guillermo Izquierdo, Raymond M.M. Hupperts, Cavit Boz, Eugenio Pucci, Giorgio Giuliani, Patrizia Sola, Daniele L.A. Spitaleri, Jeannette Lechner-Scott, Roberto Bergamaschi, François Grand'Maison, Franco Granella, Ludwig Kappos, Maria Trojano, Helmut Butzkueven

  • Abstract
  • Full Text
  • Full Text (PDF)
• Diagnostic value of serum prolactin levels in PNES in the epilepsy monitoring unit

  Abuhuziefa Abubakr, Ilse Wambacq

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Differing trends in the incidence of vascular comorbidity in MS and the general population

  Ruth Ann Marrie, John Fisk, Helen Tremlett, Christina Wolfson, Sharon Warren, James Blanchard, Scott B. Patten, for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis

  • Abstract
  • Full Text
  • Full Text (PDF)